Sonder Capital is a venture capital firm founded in 2019 and based in San Carlos, California. The firm specializes in investing in teams and technologies within the medical device, diagnostic, and health technology sectors. Sonder Capital focuses on early-stage investments, providing both financial support and strategic guidance to companies from their inception through to acquisition or initial public offering. With a commitment to transformative ideas, Sonder Capital aims to identify and nurture innovative solutions that have the potential to significantly impact healthcare and improve lives. The firm operates as a Registered Investment Adviser (RIA), ensuring compliance with industry regulations while pursuing its investment objectives.
Neptune Medical is a venture capital-funded start-up focused on developing, manufacturing, and commercializing single-use medical devices specifically for gastroenterology. The company creates innovative devices aimed at enhancing patient outcomes and increasing the safety and precision of minimally invasive procedures. Their proprietary technology allows for superior tip control, enabling the endoscope to maneuver effectively in various anatomies while maintaining an open lumen to facilitate scope swapping and re-insertion without complications. This design improves the efficiency of procedures, reduces anesthesia time, and enhances patient comfort, making Neptune Medical's products valuable assets in both gastroenterology and broader endoscopic applications.
Jupiter Endovascular
Series A in 2024
Jupiter Endovascular is a medical technology startup focused on advancing endovascular procedures through its innovative endoportal procedure. This approach utilizes an endoportal device that can navigate the vascular system with flexibility via percutaneous access. Once positioned, the device stabilizes to deliver interventional treatments with a level of precision and control that resembles traditional surgical methods. By enhancing the capabilities of catheter-based interventions, Jupiter Endovascular aims to address the limitations commonly associated with existing catheter technologies, thereby improving outcomes for healthcare professionals and their patients.
Vitestro
Series A in 2024
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.
Vitestro
Series A in 2023
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.
Wondr Medical
Seed Round in 2022
Wondr Medical is a London-based company that operates a platform designed to connect health professionals globally. Established in 2016, the platform facilitates innovation and collaboration within the healthcare sector by enabling professionals to share ideas, stay informed, and discover medical events. It also assists users in job searches, creating a comprehensive network that enhances communication among medical teams. Through its services, Wondr Medical aims to accelerate discovery in the health industry.
G.I. Windows
Series A in 2020
G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, specializing in the manufacture of medical devices that utilize surgical anastomotic technology. Founded in 2012, the company aims to revolutionize surgical procedures by developing less invasive techniques for treating obesity and type 2 diabetes. G.I. Windows is focused on creating innovative solutions that not only enhance patient outcomes but also contribute to cost reduction in the healthcare system. Through its commitment to advancing surgical technology, the company seeks to establish a new category in healthcare, enabling the development of procedures that are novel and less invasive.
Avail Medsystems
Series A in 2020
Avail Medsystems, Inc. is a digital healthcare company that develops a platform designed to remotely connect healthcare experts with practitioners. The company's integrated audio/visual hardware and software system facilitates procedural support, observation, and clinical education services, allowing healthcare professionals to collaborate effectively. By enabling real-time access to clinical expertise, Avail aims to eliminate physical, economic, and logistical barriers in the healthcare industry. This approach promotes innovation and enhances the adoption of medical tools and techniques, ultimately improving patient care. Founded in 2017 and based in Palo Alto, California, Avail Medsystems was previously known as Nurep, Inc. and underwent a name change in March 2018.
BRIUS
Series A in 2020
Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.
G.I. Windows
Series A in 2019
G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, specializing in the manufacture of medical devices that utilize surgical anastomotic technology. Founded in 2012, the company aims to revolutionize surgical procedures by developing less invasive techniques for treating obesity and type 2 diabetes. G.I. Windows is focused on creating innovative solutions that not only enhance patient outcomes but also contribute to cost reduction in the healthcare system. Through its commitment to advancing surgical technology, the company seeks to establish a new category in healthcare, enabling the development of procedures that are novel and less invasive.
Potrero Medical
Series C in 2018
Potrero Medical, Inc. is a healthcare technology company focused on developing advanced monitoring devices that detect subtle changes in physiological parameters to enhance patient care in critical settings. Its innovative products provide early warnings for conditions such as sepsis and systemic inflammatory response syndrome, while also optimizing treatment by monitoring fluid levels during resuscitation. The company's devices measure various metrics, including intra-abdominal pressure, core body temperature, heart rate, respiratory rate, relative cardiac output, and urine output. Founded in 2011 and headquartered in Hayward, California, Potrero Medical aims to leverage smart sensors and artificial intelligence to create a predictive health platform that assists medical teams in anticipating adverse outcomes in critical care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.